{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T22:49:31Z","timestamp":1791758971782,"version":"4.3.4"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-024-12015-7","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T08:24:29Z","timestamp":1734510269000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pharmacist-led interventions for vascular surgery patients: a prospective study on reducing drug-related problems"],"prefix":"10.1186","volume":"24","author":[{"given":"Slavka","family":"Porubcova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Szmicsekova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Lajtmanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Slezakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Jakubik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Drobna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Tomka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Kobliskova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Masarykova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubica","family":"Lehocka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Tesar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"issue":"9","key":"12015_CR1","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"V Aboyans","year":"2018","unstructured":"Aboyans V, Ricco JB, Bartelink MLEL, Bj\u00f6rck M, Brodmann M, Cohnert T, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesendorsed by: the European Stroke Organization (ESO)the task force for the diagnosis and treatment of peripheral arterial diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39(9):763\u2013816.","journal-title":"Eur Heart J."},{"issue":"12","key":"12015_CR2","first-page":"e686","volume":"135","author":"MD Gerhard-Herman","year":"2017","unstructured":"Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, et al. 2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135(12):e686\u2013725.","journal-title":"Circulation."},{"issue":"2 Suppl 1","key":"12015_CR3","first-page":"175","volume":"55","author":"N Hohn","year":"2014","unstructured":"Hohn N, Langer S, Kalder J, Jacobs MJ, Marx G, Eisert A. Optimizing the pharmacotherapy of vascular surgery patients by medication reconciliation. J Cardiovasc Surg (Torino). 2014;55(2 Suppl 1):175\u201381.","journal-title":"J Cardiovasc Surg (Torino)"},{"issue":"16","key":"12015_CR4","doi-asserted-by":"publisher","first-page":"10060","DOI":"10.3390\/ijerph191610060","volume":"19","author":"YH Khan","year":"2022","unstructured":"Khan YH, Alzarea AI, Alotaibi NH, Alatawi AD, Khokhar A, Alanazi AS, et al. Evaluation of impact of a pharmacist-led educational campaign on disease knowledge, practices and medication adherence for type-2 diabetic patients: a prospective pre- and post-analysis. Int J Environ Res Public Health. 2022;19(16):10060.","journal-title":"Int J Environ Res Public Health."},{"issue":"5","key":"12015_CR5","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.jvs.2018.07.027","volume":"68","author":"SL Parvar","year":"2018","unstructured":"Parvar SL, Fitridge R, Dawson J, Nicholls SJ. Medical and lifestyle management of peripheral arterial disease. J Vasc Surg. 2018;68(5):1595\u2013606.","journal-title":"J Vasc Surg"},{"issue":"4","key":"12015_CR6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s40266-023-01015-7","volume":"40","author":"J Wang","year":"2023","unstructured":"Wang J, James S, Hilmer SN, Aitken SJ, Soo G, Naganathan V, et al. Optimising medications in older vascular surgery patients through geriatric co-management. Drugs Aging. 2023;40(4):335\u201342.","journal-title":"Drugs Aging."},{"issue":"4","key":"12015_CR7","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3390\/medicina59040780","volume":"59","author":"KP Schmelzer","year":"2023","unstructured":"Schmelzer KP, Liebetrau D, K\u00e4mmerer W, Meisinger C, Hyhlik-D\u00fcrr A. Strategies for avoiding typical drug-drug interactions and drug-related problems in patients with vascular diseases. Medicina (Kaunas). 2023;59(4):780.","journal-title":"Medicina (Kaunas)."},{"issue":"e1","key":"12015_CR8","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1136\/ejhpharm-2017-001239","volume":"25","author":"E Kiesel","year":"2018","unstructured":"Kiesel E, Hopf Y. Hospital pharmacists working with geriatric patients in Europe: a systematic literature review. Eur J Hosp Pharm marec. 2018;25(e1):e74\u201381.","journal-title":"Eur J Hosp Pharm marec"},{"issue":"1","key":"12015_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2147\/tcrm.1.1.39.53597","volume":"1","author":"Y Koh","year":"2005","unstructured":"Koh Y, Kutty FBM, Li SC. Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender. Ther Clin Risk Manag. 2005;1(1):39\u201348.","journal-title":"Ther Clin Risk Manag"},{"issue":"5","key":"12015_CR10","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.farma.2011.02.005","volume":"35","author":"I Mart\u00ednez L\u00f3pez","year":"2011","unstructured":"Mart\u00ednez L\u00f3pez I, Do Pazo-Oubi\u00f1a F, Lozano VP. Comprehensive pharmaceutical care in a vascular surgery department. Farm Hosp. 2011;35(5):260\u20133.","journal-title":"Farm Hosp."},{"key":"12015_CR11","unstructured":"European Statements of Hospital Pharmacy | European Association of Hospital Pharmacists. Available at: https:\/\/www.eahp.eu\/hp-practice\/hospital-pharmacy\/european-statements-hospital-pharmacy. Cit 03 Okt\u00f3ber 2023."},{"issue":"Suppl 2","key":"12015_CR12","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1136\/ejhpharm-2020-002206","volume":"28","author":"S AbuRuz","year":"2021","unstructured":"AbuRuz S, Jaber D, Basheti I, Sadeq A, Arafat M, AlAhmad M, et al. Impact of pharmacist interventions on drug-related problems in general surgery patients: a randomised controlled trial. Eur J Hosp Pharm. 2021;28(Suppl 2):e72\u20138.","journal-title":"Eur J Hosp Pharm"},{"key":"12015_CR13","unstructured":"Pharmaceutical Care Network Europe Association Classification for drug related problems V 9.1. The PCNE Classification V 9.1. 2020. Available at: https:\/\/www.pcne.org\/upload\/files\/417_PCNE_classification_V9-1_final.pdf."},{"issue":"9237","key":"12015_CR14","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","volume":"356","author":"IR Edwards","year":"2000","unstructured":"Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356(9237):1255\u20139.>","journal-title":"Lancet"},{"issue":"5","key":"12015_CR15","doi-asserted-by":"publisher","first-page":"481","DOI":"10.7861\/clinmedicine.16-5-481","volume":"16","author":"JJ Coleman","year":"2016","unstructured":"Coleman JJ, Pontefract SK. Adverse drug reactions. Clin Med (Lond). 2016;16(5):481\u20135.","journal-title":"Clin Med (Lond)."},{"issue":"5","key":"12015_CR16","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1093\/intqhc\/mzp034","volume":"21","author":"SD Williams","year":"2009","unstructured":"Williams SD, Ashcroft DM. Medication errors: how reliable are the severity ratings reported to the national reporting and learning system? Int J Qual Health Care. 2009;21(5):316\u201320.","journal-title":"Int J Qual Health Care"},{"issue":"4","key":"12015_CR17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jcrc.2003.10.001","volume":"18","author":"P Pronovost","year":"2003","unstructured":"Pronovost P, Weast B, Schwarz M, Wyskiel RM, Prow D, Milanovich SN, et al. Medication reconciliation: a practical tool to reduce the risk of medication errors. J Crit Care. 2003;18(4):201\u20135.","journal-title":"J Crit Care"},{"issue":"2","key":"12015_CR18","doi-asserted-by":"publisher","first-page":"e010003","DOI":"10.1136\/bmjopen-2015-010003","volume":"6","author":"AB Mekonnen","year":"2016","unstructured":"Mekonnen AB, McLachlan AJ, Brien JA. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis. BMJ Open. 2016;6(2):e010003.","journal-title":"BMJ Open."},{"issue":"4","key":"12015_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.9740\/mhc.n117761","volume":"2","author":"K Allison","year":"2012","unstructured":"Allison K. Adherence through education: a call to clinicians to educate all patients on medication use. Mental Health Clinician. 2012;2(4):83\u20135.","journal-title":"Mental Health Clinician."},{"issue":"8","key":"12015_CR20","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1080\/0142159X.2019.1597258","volume":"41","author":"J Hearn","year":"2019","unstructured":"Hearn J, Dewji M, Stocker C, Simons G. Patient-centered medical education: a proposed definition. Med Teach. 2019;41(8):934\u20138.","journal-title":"Med Teach."},{"issue":"2","key":"12015_CR21","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1136\/ejhpharm-2016-000901","volume":"25","author":"U Gillespie","year":"2018","unstructured":"Gillespie U, Eriksson T. Medication reconciliation activities among pharmacists in Europe. Eur J Hosp Pharm marec. 2018;25(2):100\u20132.","journal-title":"Eur J Hosp Pharm marec"},{"issue":"1","key":"12015_CR22","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/s41598-020-80560-2","volume":"11","author":"N Garin","year":"2021","unstructured":"Garin N, Sole N, Lucas B, Matas L, Moras D, Rodrigo-Troyano A, et al. Drug related problems in clinical practice: a cross-sectional study on their prevalence, risk factors and associated pharmaceutical interventions. Sci Rep. 2021;11(1):883.","journal-title":"Sci Rep"},{"key":"12015_CR23","doi-asserted-by":"crossref","unstructured":"Spencer J, McKimm J. Patient involvement in medical education. Understanding Medical Education: Evidence, Theory and Practice. 2010. Available at: https:\/\/eprints.ncl.ac.uk.\u00a0Cit 29 J\u00fal 2024.","DOI":"10.1002\/9781444320282.ch13"},{"issue":"5","key":"12015_CR24","first-page":"359","volume":"63","author":"R Johnston","year":"2010","unstructured":"Johnston R, Saulnier L, Gould O. Best possible medication history in the emergency department: comparing pharmacy technicians and pharmacists. Can J Hosp Pharm september. 2010;63(5):359\u201365.","journal-title":"Can J Hosp Pharm september"},{"issue":"2","key":"12015_CR25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/intqhc\/mzu010","volume":"26","author":"A Leotsakos","year":"2014","unstructured":"Leotsakos A, Zheng H, Croteau R, Loeb JM, Sherman H, Hoffman C, et al. Standardization in patient safety: the WHO High 5s project. Int J Qual Health Care. 2014;26(2):109\u201316.","journal-title":"Int J Qual Health Care"},{"key":"12015_CR26","unstructured":"Overview | Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes | Guidance | NICE. NICE; 2015. Available at: https:\/\/www.nice.org.uk\/guidance\/ng5. Cit 12 Febru\u00e1r 2024."},{"issue":"2","key":"12015_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1053\/j.semvascsurg.2022.04.003","volume":"35","author":"JM Dittman","year":"2022","unstructured":"Dittman JM, Amendola MF, Lavingia KS. Medical optimization of the peripheral artery disease patient. Semin Vasc Surg. 2022;35(2):113\u201323.","journal-title":"Semin Vasc Surg"},{"issue":"3","key":"12015_CR28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4321\/S1885-642X2006000300001","volume":"4","author":"EC Chumney","year":"2006","unstructured":"Chumney EC, Robinson LC. The effects of pharmacist interventions on patients with polypharmacy. Pharm Pract (Granada). 2006;4(3):103\u20139.","journal-title":"Pharm Pract (Granada)"},{"issue":"9","key":"12015_CR29","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1001\/archinternmed.2009.71","volume":"169","author":"U Gillespie","year":"2009","unstructured":"Gillespie U, Alassaad A, Henrohn D, Garmo H, Hammarlund-Udenaes M, Toss H, et al. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med. 2009;169(9):894\u2013900.","journal-title":"Arch Intern Med"},{"key":"12015_CR30","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2147\/TCRM.S98300","volume":"12","author":"XB Zhai","year":"2016","unstructured":"Zhai XB, Gu ZC, Liu XY. Effectiveness of the clinical pharmacist in reducing mortality in hospitalized cardiac patients: a propensity score-matched analysis. Ther Clin Risk Manag. 2016;12:241\u201350.","journal-title":"Ther Clin Risk Manag"},{"issue":"5","key":"12015_CR31","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"issue":"12","key":"12015_CR32","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1136\/bmjqs-2015-004411","volume":"25","author":"G Ogrinc","year":"2016","unstructured":"Ogrinc G, Davies L, Goodman D, Batalden P, Davidoff F, Stevens D. SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process. BMJ Qual Saf. 2016;25(12):986\u201392.","journal-title":"BMJ Qual Saf"},{"key":"12015_CR33","unstructured":"Pharmaceutical Care Practice: The Patient-Centered Approach to Medication Management Services, 3e | AccessPharmacy | McGraw Hill Medical. Available at: https:\/\/accesspharmacy.mhmedical.com\/book.aspx?bookID=491. Cit 29 J\u00fal 2024."},{"issue":"3","key":"12015_CR34","first-page":"533","volume":"47","author":"CD Hepler","year":"1990","unstructured":"Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm marec. 1990;47(3):533\u201343.","journal-title":"Am J Hosp Pharm marec"},{"issue":"7","key":"12015_CR35","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00228-015-1860-9","volume":"71","author":"A Renom-Guiteras","year":"2015","unstructured":"Renom-Guiteras A, Meyer G, Th\u00fcrmann PA. The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries. Eur J Clin Pharmacol j\u00fal. 2015;71(7):861\u201375.","journal-title":"Eur J Clin Pharmacol j\u00fal"},{"key":"12015_CR36","unstructured":"WHO Anatomical Therapeutic Chemical (ATC) Classification - PubChem Data Source. Available at: https:\/\/pubchem.ncbi.nlm.nih.gov\/source\/11950. Cit 03 Okt\u00f3ber 2023."},{"issue":"4","key":"12015_CR37","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","volume":"41","author":"F Faul","year":"2009","unstructured":"Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41(4):1149\u201360.","journal-title":"Behav Res Methods"},{"key":"12015_CR38","unstructured":"Understanding The New Statistics | Effect Sizes, Confidence Intervals. Available at: https:\/\/www.taylorfrancis.com\/books\/mono\/ https:\/\/doi.org\/10.4324\/9780203807002\/understanding-new-statistics-geoff-cumming. Cit 29 J\u00fal 2024."},{"key":"12015_CR39","unstructured":"Statistical Power Analysis for the Behavioral Sciences | Jacob Cohen |. Available at: https:\/\/www.taylorfrancis.com\/books\/mono\/ https:\/\/doi.org\/10.4324\/9780203771587\/statistical-power-analysis-behavioral-sciences-jacob-cohen. Cit 29 J\u00fal 2024."},{"issue":"2","key":"12015_CR40","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S1388-9842(99)00014-8","volume":"1","author":"CM Cline","year":"1999","unstructured":"Cline CM, Bj\u00f6rck-Linn\u00e9 AK, Israelsson BY, Willenheimer RB, Erhardt LR. Non-compliance and knowledge of prescribed medication in elderly patients with heart failure. Eur J Heart Fail. 1999;1(2):145\u20139.","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"12015_CR41","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4321\/S1886-36552013000200002","volume":"11","author":"AF Marfo","year":"2013","unstructured":"Marfo AF, Owusu-Daaku FT, Kyerewaa-Akromah E. Patient knowledge of medicines dispensed from Ghanaian community pharmacies. Pharm Pract (Granada). 2013;11(2):66\u201370.","journal-title":"Pharm Pract (Granada)."},{"issue":"7","key":"12015_CR42","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1046\/j.1365-3156.2003.01076.x","volume":"8","author":"E Boonstra","year":"2003","unstructured":"Boonstra E, Lindb\u00e6k M, Klouman E, Ngome E, Rom\u00f8ren M, Sundby J. Syndromic management of sexually transmitted diseases in Botswana\u2019s primary health care: quality of care aspects. Tropical Med Int Health. 2003;8(7):604\u201314.","journal-title":"Tropical Med Int Health"},{"key":"12015_CR43","unstructured":"Zdravotn\u00edcka rocenka]. Available at: https:\/\/www.nczisk.sk\/Statisticke_vystupy\/Zdravotnicka_rocenka\/Pages\/default.aspx. Cit 29 J\u00fal 2024."},{"key":"12015_CR44","first-page":"37","volume":"6","author":"K Dalton","year":"2017","unstructured":"Dalton K, Byrne S. Role of the pharmacist in reducing healthcare costs: current insights. Integr Pharm Res Pract. 2017;6:37\u201346.","journal-title":"Integr Pharm Res Pract"},{"issue":"4","key":"12015_CR45","doi-asserted-by":"publisher","first-page":"e0174513","DOI":"10.1371\/journal.pone.0174513","volume":"12","author":"F Karapinar-\u00c7arkit","year":"2017","unstructured":"Karapinar-\u00c7arkit F, van der Knaap R, Bouhannouch F, Borgsteede SD, Janssen MJA, Siegert CEH, et al. Cost-effectiveness of a transitional pharmaceutical care program for patients discharged from the hospital. PLoS One. 2017;12(4):e0174513.","journal-title":"PLoS One"},{"issue":"6","key":"12015_CR46","doi-asserted-by":"publisher","first-page":"e001461","DOI":"10.1136\/bmjopen-2012-001461","volume":"2","author":"KK Viktil","year":"2012","unstructured":"Viktil KK, Blix HS, Eek AK, Davies MN, Moger TA, Reikvam A. How are drug regimen changes during hospitalisation handled after discharge: a cohort study. BMJ Open. 2012;2(6):e001461.","journal-title":"BMJ Open."},{"issue":"2","key":"12015_CR47","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jemermed.2022.04.016","volume":"63","author":"JD Haag","year":"2022","unstructured":"Haag JD, Bellamkonda VR, Perinpam L, Peters BJ, Sunga KL, Gross CL, et al. Prevalence and categorization of drug-related problems in the emergency department. J Emerg Med. 2022;63(2):192\u20139.","journal-title":"J Emerg Med"},{"issue":"8","key":"12015_CR48","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.3390\/jcm10081788","volume":"10","author":"YK Song","year":"2021","unstructured":"Song YK, Jeong S, Han N, Na H, Jang HY, Sohn M, et al. Effectiveness of clinical pharmacist service on drug-related problems and patient outcomes for hospitalized patients with chronic kidney disease: a randomized controlled trial. J Clin Med. 2021;10(8):1788.","journal-title":"J Clin Med."},{"key":"12015_CR49","doi-asserted-by":"publisher","first-page":"698907","DOI":"10.3389\/fphar.2021.698907","volume":"12","author":"XF Ni","year":"2021","unstructured":"Ni XF, Yang CS, Bai YM, Hu ZX, Zhang LL. Drug-related problems of patients in primary health care institutions: a systematic review. Front Pharmacol. 2021;12:698907.","journal-title":"Front Pharmacol."},{"key":"12015_CR50","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12872-024-03710-8","volume":"24","author":"YL Niriayo","year":"2024","unstructured":"Niriayo YL, Kifle R, Asgedom SW, Gidey K. Drug therapy problems among hospitalized patients with cardiovascular disease. BMC Cardiovasc Disord. 2024;24:50.","journal-title":"BMC Cardiovasc Disord."},{"issue":"1","key":"12015_CR51","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12873-024-01102-x","volume":"24","author":"P Phoemlap","year":"2024","unstructured":"Phoemlap P, Vadcharavivad S, Musikatavorn K, Areepium N. Prevalence and factors associated with preventable drug-related emergency department visits (DREDp) in elderly patients. BMC Emerg Med. 2024;24(1):197.","journal-title":"BMC Emerg Med."},{"issue":"7","key":"12015_CR52","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/phar.1777","volume":"36","author":"J Rychl\u00edckov\u00e1","year":"2016","unstructured":"Rychl\u00edckov\u00e1 J, \u0160aloun J, Gregorov\u00e1 J. Evaluation of Clinical Pharmacists\u2019 Interventions in the Czech Republic. Pharmacotherapy j\u00fal. 2016;36(7):766\u201373.","journal-title":"Pharmacotherapy j\u00fal"},{"key":"12015_CR53","unstructured":"www.MeDitorial.cz . Venujeme medikaci senioru dostatecnou p\u00e9ci? (Pr\u00edpad Domova\u2026. Available at: https:\/\/www.prolekare.cz\/casopisy\/vnitrni-lekarstvi\/2021-e-5\/venujeme-medikaci-senioru-dostatecnou-peci-pripad-domova-vlci-mak-uvn-praha-130075. Cit 29 J\u00fal 2024."},{"issue":"5","key":"12015_CR54","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.sapharm.2019.08.001","volume":"16","author":"BD Fernandes","year":"2020","unstructured":"Fernandes BD, Almeida PHRF, Foppa AA, Sousa CT, Ayres LR, Chemello C. Pharmacist-led medication reconciliation at patient discharge: a scoping review. Res Social Adm Pharm. 2020;16(5):605\u201313.","journal-title":"Res Social Adm Pharm."},{"issue":"1","key":"12015_CR55","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11096-022-01496-3","volume":"45","author":"H Studer","year":"2023","unstructured":"Studer H, Imfeld-Isenegger TL, Beeler PE, Ceppi MG, Rosen C, Bodmer M, et al. The impact of pharmacist-led medication reconciliation and interprofessional ward rounds on drug-related problems at hospital discharge. Int J Clin Pharm. 2023;45(1):117\u201325.","journal-title":"Int J Clin Pharm"},{"issue":"7","key":"12015_CR56","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.jacc.2013.09.073","volume":"63","author":"GG Westin","year":"2014","unstructured":"Westin GG, Armstrong EJ, Bang H, Yeo KK, Anderson D, Dawson DL, et al. Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival in patients with critical limb ischemia. J Am Coll Cardiol. 2014;63(7):682\u201390.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"12015_CR57","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.jvs.2018.03.004","volume":"67","author":"AJ Meltzer","year":"2018","unstructured":"Meltzer AJ, Sedrakyan A, Connolly PH, Ellozy S, Schneider DB. Risk factors for suboptimal utilization of statins and antiplatelet therapy in patients undergoing revascularization for symptomatic peripheral arterial disease. J Vasc Surg. 2018;67(5):1628 01. m\u00e1j.","journal-title":"J Vasc Surg"},{"issue":"3","key":"12015_CR58","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1177\/1358863X18758914","volume":"23","author":"CL McBride","year":"2018","unstructured":"McBride CL, Akeroyd JM, Ramsey DJ, Nambi V, Nasir K, Michos ED, et al. Statin prescription rates and their facility-level variation in patients with peripheral artery disease and ischemic cerebrovascular disease: Insights from the Department of Veterans Affairs. Vasc Med j\u00fan. 2018;23(3):232\u201340.","journal-title":"Vasc Med j\u00fan"},{"issue":"12","key":"12015_CR59","doi-asserted-by":"publisher","first-page":"e2136014","DOI":"10.1001\/jamanetworkopen.2021.36014","volume":"4","author":"N Singh","year":"2021","unstructured":"Singh N, Ding L, Devera J, Magee GA, Garg PK. Prescribing of statins after lower extremity revascularization procedures in the US. JAMA Netw Open. 2021;4(12):e2136014.","journal-title":"JAMA Netw Open."},{"issue":"4","key":"12015_CR60","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1053\/j.gastro.2021.12.247","volume":"162","author":"LE Targownik","year":"2022","unstructured":"Targownik LE, Fisher DA, Saini SD. AGA clinical practice update on de-prescribing of proton pump inhibitors: expert review. Gastroenterology. 2022;162(4):1334\u201342.","journal-title":"Gastroenterology."},{"issue":"11","key":"12015_CR61","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1111\/j.1572-0241.2008.02107.x","volume":"103","author":"A Pilotto","year":"2008","unstructured":"Pilotto A, Franceschi M, Vitale D, Zaninelli A, Di Mario F, Seripa D, et al. The prevalence of diarrhea and its association with drug use in elderly outpatients: a multicenter study. Am J Gastroenterol. 2008;103(11):2816\u201323.","journal-title":"Am J Gastroenterol."},{"issue":"5","key":"12015_CR62","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1046\/j.1365-2710.2000.00312.x","volume":"25","author":"M Naunton","year":"2000","unstructured":"Naunton M, Peterson GM, Bleasel MD. Overuse of proton pump inhibitors. J Clin Pharm Ther. 2000;25(5):333\u201340.","journal-title":"J Clin Pharm Ther."},{"issue":"1","key":"12015_CR63","doi-asserted-by":"publisher","first-page":"16","DOI":"10.5694\/j.1326-5377.2000.tb123871.x","volume":"172","author":"PI Pillans","year":"2000","unstructured":"Pillans PI, Kubler PA, Radford JM, Overland V. Concordance between use of proton pump inhibitors and prescribing guidelines. Med J Aust. 2000;172(1):16\u20138.","journal-title":"Med J Aust."},{"issue":"22","key":"12015_CR64","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1001\/jama.2013.280490","volume":"310","author":"JR Lam","year":"2013","unstructured":"Lam JR, Schneider JL, Zhao W, Corley DA. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA. 2013;310(22):2435\u201342.","journal-title":"JAMA."},{"key":"12015_CR65","doi-asserted-by":"publisher","unstructured":"Tawam D, Baladi M, Jungsuwadee P, Earl G, Han J. The Positive Association between Proton Pump Inhibitors and Clostridium Difficile Infection. Innov Pharm. 09. marec 2021;12(1). https:\/\/doi.org\/10.24926\/iip.v12i1.3439.","DOI":"10.24926\/iip.v12i1.3439"},{"issue":"4","key":"12015_CR66","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.bone.2010.12.015","volume":"48","author":"CS Kwok","year":"2011","unstructured":"Kwok CS, Yeong JKY, Loke YK. Meta-analysis: risk of fractures with acid-suppressing medication. Bone. 2011;48(4):768\u201376.","journal-title":"Bone."},{"issue":"3","key":"12015_CR67","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4292\/wjgpt.v2.i3.17","volume":"2","author":"AL Fohl","year":"2011","unstructured":"Fohl AL, Regal RE. Proton pump inhibitor-associated pneumonia: not a breath of fresh air after all? World J Gastrointest Pharmacol Ther. 2011;2(3):17\u201326.","journal-title":"World J Gastrointest Pharmacol Ther."},{"issue":"11","key":"12015_CR68","doi-asserted-by":"publisher","first-page":"e040473","DOI":"10.1136\/bmjopen-2020-040473","volume":"10","author":"Y Liu","year":"2020","unstructured":"Liu Y, Zhu X, Li R, Zhang J, Zhang F. Proton pump inhibitor utilisation and potentially inappropriate prescribing analysis: insights from a single-centred retrospective study. BMJ Open. 2020;10(11):e040473.","journal-title":"BMJ Open."},{"issue":"9","key":"12015_CR69","doi-asserted-by":"publisher","first-page":"617","DOI":"10.14740\/jocmr3906","volume":"11","author":"DJ Safer","year":"2019","unstructured":"Safer DJ. Overprescribed medications for US adults: four major examples. J Clin Med Res. 2019;11(9):617\u201322.","journal-title":"J Clin Med Res."},{"issue":"4","key":"12015_CR70","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/1756283X12437358","volume":"5","author":"JJ Heidelbaugh","year":"2012","unstructured":"Heidelbaugh JJ, Kim AH, Chang R, Walker PC. Overutilization of proton-pump inhibitors: what the clinician needs to know. Therap Adv Gastroenterol. 2012;5(4):219\u201332.","journal-title":"Therap Adv Gastroenterol."},{"issue":"7634","key":"12015_CR71","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1136\/bmj.39406.449456.BE","volume":"336","author":"I Forgacs","year":"2008","unstructured":"Forgacs I, Loganayagam A. Overprescribing proton pump inhibitors. BMJ. 2008;336(7634):2\u20133.","journal-title":"BMJ."},{"issue":"4","key":"12015_CR72","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/jcpt.13395","volume":"46","author":"L Veremme","year":"2021","unstructured":"Veremme L, Janoly-Dumenil A, Charpiat B. Curbing proton pump inhibitor overprescribing: multifaceted strategies in an academic hospital. J Clin Pharm Ther. 2021;46(4):1041\u20135.","journal-title":"J Clin Pharm Ther."},{"issue":"4","key":"12015_CR73","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1001\/archinte.165.4.424","volume":"165","author":"PL Cornish","year":"2005","unstructured":"Cornish PL, Knowles SR, Marchesano R, Tam V, Shadowitz S, Juurlink DN, et al. Unintended medication discrepancies at the time of hospital admission. Arch Intern Med. 2005;165(4):424\u20139.","journal-title":"Arch Intern Med"},{"issue":"1","key":"12015_CR74","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1186\/s12913-022-08628-5","volume":"22","author":"TA Moges","year":"2022","unstructured":"Moges TA, Akalu TY, Sema FD. Unintended medication discrepancies and associated factors upon patient admission to the internal medicine wards: identified through medication reconciliation. BMC Health Serv Res. 2022;22(1):1251.","journal-title":"BMC Health Serv Res"},{"key":"12015_CR75","doi-asserted-by":"crossref","unstructured":"Sentinel event alert. dangerous tubing: mis: connections. Advances in Neonatal Care. 2006;6(5):225.","DOI":"10.1016\/j.adnc.2006.06.003"},{"issue":"SP","key":"12015_CR76","first-page":"150","volume":"10","author":"JI Mitchell","year":"2014","unstructured":"Mitchell JI, Nicklin W, Macdonald B. The accreditation Canada program: a complementary tool to promote accountability in canadian healthcare. Healthc Policy. 2014;10(SP):150\u20133.","journal-title":"Healthc Policy."},{"key":"12015_CR77","unstructured":"Medication reconciliation | Australian Commission on Safety and Quality in Health Care. Available at: https:\/\/www.safetyandquality.gov.au\/our-work\/medication-safety\/medication-reconciliation. Cit 12 Febru\u00e1r 2024."},{"issue":"6","key":"12015_CR78","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.sapharm.2017.06.009","volume":"14","author":"R Fredericksen","year":"2018","unstructured":"Fredericksen R, Gibbons L, Brown S, Edwards T, Yang FM, Fitzsimmons E, et al. Medication understanding among patients living with multiple chronic conditions: implications for patient-reported measures of adherence. Res Social Adm Pharm. 2018;14(6):540\u20134.","journal-title":"Res Social Adm Pharm"},{"issue":"9","key":"12015_CR79","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1097\/00005650-200209000-00009","volume":"40","author":"MR DiMatteo","year":"2002","unstructured":"DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40(9):794\u2013811.","journal-title":"Med Care"},{"issue":"2","key":"12015_CR80","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/jhm.566","volume":"5","author":"E Cumbler","year":"2010","unstructured":"Cumbler E, Wald H, Kutner J. Lack of patient knowledge regarding hospital medications. J Hosp Med. 2010;5(2):83\u20136.","journal-title":"J Hosp Med"},{"key":"12015_CR81","doi-asserted-by":"publisher","first-page":"1009485","DOI":"10.3389\/fphar.2022.1009485","volume":"13","author":"S Park","year":"2022","unstructured":"Park S, Kim AJ, Ah YM, Lee MY, Lee YJ, Chae J, et al. Prevalence and predictors of medication-related emergency department visit in older adults: a multicenter study linking national claim database and hospital medical records. Front Pharmacol. 2022;13:1009485.","journal-title":"Front Pharmacol."},{"key":"12015_CR82","doi-asserted-by":"crossref","unstructured":"Huang X, Estau D, Liu X, Yu Y, Qin J, Li Z. Evaluating the performance of ChatGPT in clinical pharmacy: a comparative study of ChatGPT and clinical pharmacists. Br J Clin Pharmacol. 2024;90(1):232\u20138.","DOI":"10.1111\/bcp.15896"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-024-12015-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-024-12015-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-024-12015-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T10:28:10Z","timestamp":1734517690000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-024-12015-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12015"],"URL":"https:\/\/doi.org\/10.1186\/s12913-024-12015-7","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"8 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the National Institute of Cardiovascular Diseases (Approval Number 1625\/21, 26th May 2021) and the ClinicalTrials.gov (Trial Registration Number NCT04930302, 16th June 2021). All procedures performed in this study were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable. Written informed consent was obtained from all subjects before the initiation of any research-related activities. The consent form used was approved by the Ethics Committee and was presented in the Slovak language, ensuring participants could read and comprehend it. By signing the informed consent, participants agreed to the publication and presentation of their pseudonymized analysed data.Patients\u2019 personal data were anonymised to ensure confidentiality. The Participant Identification Sheet was securely stored at the study centre along with other documentation. Anonymised data were then entered into the case report form in the online database MIA DMS, which operates in Europe.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1564"}}